Chandra Bhagat Pharma Limited
CBPL
Rank in Stocks
#30654
Chandra Bhagat Pharma Ltd. specializes in the distribution and... Chandra Bhagat Pharma Ltd. specializes in the distribution and commercialization of a diverse array of pharmaceutical, critical care, and general healthcare solutions. Their extensive product lineup encompasses various pharmaceutical formulations, notably intravenous (IV) and intramuscular (IM) injectable medications, alongside select tablet forms, serving both national and international clientele. Furthermore, the company actively promotes and markets active pharmaceutical ingredients (APIs). Their offerings are designed to address a spectrum of conditions, including rheumatoid and osteo-arthritis, osteoporosis, carpal tunnel syndrome, tendonitis, rotator cuff tears, muscular dystrophy, myasthenia gravis, and lupus erythematosus, among other health issues. Established in 1944 by Chandravadan C. Bhagat, the company's main operations are based in Mumbai, India.
Share Price
$0.61577238
Last synced: 2026-11-09
Market Cap
$4.65M
Change (1 day)
4.19%
Change (1 year)
36.56%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Chandra Bhagat Pharma Limited (CBPL)
Category
Healthcare
EPS for Chandra Bhagat Pharma Limited (CBPL)
EPS as of March 2026 TTM: $0.04
According to Chandra Bhagat Pharma Limited's latest financial reports, its current EPS (TTM) is $0.04. At the end of 2025 the company had an EPS of $0.01, a decrease compared to its 2024 EPS of $0.02.
EPS history for Chandra Bhagat Pharma Limited from 2017 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.04 | 322.00% |
| 2025 | $0.01 | -45.27% |
| 2024 | $0.02 | 66.44% |
| 2023 | $0.01 | 4.29% |
| 2022 | $0.01 | 311.76% |
| 2021 | 0.00 | -53.42% |
| 2020 | $0.01 | -69.58% |
| 2019 | $0.02 | -49.47% |
| 2018 | $0.05 | 56.25% |
| 2017 | $0.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $39.05 | 92,435.55% |
US
|
|
| $17.99 | 42,530.33% |
US
|
|
| $7.77 | 18,312.32% |
US
|
|
| $17.99 | 42,530.33% |
US
|
|
| $0.04 | 3.08% |
AU
|
Questions about Chandra Bhagat Pharma Limited's earnings per share (EPS)
What is Chandra Bhagat Pharma Limited's earnings per share (EPS)?
Chandra Bhagat Pharma Limited's earnings per share (EPS) over the last twelve months is $0.04, as of Mar 2026.
What was Chandra Bhagat Pharma Limited's earnings per share (EPS) in 2025?
In 2025, Chandra Bhagat Pharma Limited's earnings per share (EPS) was $0.01, 50.00% less than in 2024 ($0.02).
How has Chandra Bhagat Pharma Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Chandra Bhagat Pharma Limited's earnings per share (EPS) went from $0.01 to $0.01, an average growth of 0.00% a year.
How does Chandra Bhagat Pharma Limited's earnings per share (EPS) compare with similar companies?
Chandra Bhagat Pharma Limited's earnings per share (EPS) ($0.04) is lower than that of all 5 similar companies listed above. The highest among them is McKesson Corporation, with $39.05.